Form 4: Slide Insurance CRO Executes Stock Option Exercise

Sentiment:

Statement of Changes in Beneficial Ownership


Chief Risk Officer Matthew Paul Larson exercised 11,250 stock options and sold the resulting shares under a 10b5-1 plan.

Summary

  • Matthew Paul Larson, Chief Risk Officer of Slide Insurance Holdings, Inc., exercised 11,250 stock options at a strike price of $0.79 per share.
  • Following the exercise, the reporting person sold all 11,250 shares at a weighted average price of $18.67 per share.
  • The transactions were executed on May 11, 2026, pursuant to a Rule 10b5-1 trading plan adopted on December 4, 2025.
  • The reporting person retains 38,998 derivative securities following these transactions.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a routine, pre-planned divestment by an executive rather than a signal of company performance.

Positives

  • The transaction was pre-planned under a Rule 10b5-1 trading plan, indicating the sale was not based on non-public information.
  • The exercise price of $0.79 compared to the sale price of $18.67 reflects significant value appreciation for the executive.

Negatives

  • The reporting person reduced their direct beneficial ownership of common stock to zero following the sale.

Risks

  • None identified; this is a routine disclosure of executive compensation and equity management.

Future Outlook

No forward-looking guidance provided in this document.

Industry Context

StockSavvy.ai notes that executive equity sales under 10b5-1 plans are standard corporate governance practices used to provide liquidity while mitigating concerns regarding insider trading.

Comparison to Industry Standards

  • The use of 10b5-1 plans is the industry standard for executives at publicly traded insurance companies to manage personal equity holdings.
  • The exercise and sale of vested options is consistent with typical executive compensation structures in the financial services sector.

Stakeholder Impact

  • Minimal impact on shareholders as the transaction was conducted via a pre-arranged 10b5-1 plan.

Next Steps

  • No future actions or milestones mentioned.

Key Dates

DateDescription
2025-12-04Date the 10b5-1 trading plan was adopted.
2026-05-11Date of the stock option exercise and subsequent share sale.
2026-05-13Date the Form 4 was signed and filed.

Keywords

Slide Insurance, SLDE, Form 4, Insider Trading, Stock Options, Chief Risk Officer

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.